| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Wai Conrad | CEO, Counterpart Health | C/O CLOVER HEALTH INVESTMENTS, CORP., NOT APPLICABLE, WILMINGTON | /s/ Peter J. Rivas as attorney-in-fact for Conrad Wai | 04 Aug 2025 | 0001971702 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CLOV | Class A Common Stock | Tax liability | $80,718 | -27,930 | -1.6% | $2.89 | 1,671,837 | 31 Jul 2025 | Direct | F1 |
| holding | CLOV | Class A Common Stock | 1,403,701 | 31 Jul 2025 | By Trust. | F2 |
| Id | Content |
|---|---|
| F1 | Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on July 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs have a final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date. |
| F2 | Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee. |